摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

24-Methyl-23-propan-2-yloxy-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.02,10.04,8.014,22.017,21]tetracosa-1(13),2,4(8),9,11,14(22),15,17(21)-octaene | 1333222-85-7

中文名称
——
中文别名
——
英文名称
24-Methyl-23-propan-2-yloxy-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.02,10.04,8.014,22.017,21]tetracosa-1(13),2,4(8),9,11,14(22),15,17(21)-octaene
英文别名
24-methyl-23-propan-2-yloxy-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.02,10.04,8.014,22.017,21]tetracosa-1(13),2,4(8),9,11,14(22),15,17(21)-octaene
24-Methyl-23-propan-2-yloxy-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.02,10.04,8.014,22.017,21]tetracosa-1(13),2,4(8),9,11,14(22),15,17(21)-octaene化学式
CAS
1333222-85-7
化学式
C23H21NO5
mdl
——
分子量
391.423
InChiKey
GHZUBLRVAAABQN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.9
  • 重原子数:
    29
  • 可旋转键数:
    2
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    49.4
  • 氢给体数:
    0
  • 氢受体数:
    6

反应信息

  • 作为产物:
    描述:
    血根碱异丙醇 在 copper chloride dihydrate 、 氧气 作用下, 反应 10.0h, 以98%的产率得到24-Methyl-23-propan-2-yloxy-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.02,10.04,8.014,22.017,21]tetracosa-1(13),2,4(8),9,11,14(22),15,17(21)-octaene
    参考文献:
    名称:
    Structural Modification of Sanguinarine and Chelerythrine and Their <i>in Vitro</i> Acaricidal Activity against <i>Psoroptes cuniculi</i>
    摘要:
    血根碱(1)和白屈菜红碱(2)是两种季铵基苯并[c]菲啶生物碱(QBAs)。通过C=N+键的修饰合成了1和2的18个衍生物,并评估了它们对兔耳螨(Psoroptes cuniculi)的体外杀螨活性。开发了一种新方法制备1和2的6-烷氧基二氢衍生物(1a–e,2a–e)。在所有化合物中,只有6-烷氧基二氢血根碱(1a–e)在5.0 mg/mL浓度下显示出显著的杀螨活性,其中1a具有最强的活性(50%致死浓度(LC50)=339.70±0.75 mg/L,50%致死时间(LT50)=6.53±0.04 h),与标准药物伊维菌素(LC50=168.19±11.79 mg/L,LT50=16.54±0.11 h)相当。1和2中的亚胺基团被证实是其杀螨活性的决定因素。6-烷氧基二氢衍生物(1a–e,2a–e)是1和2的前药。与7,8-二甲氧基相比,7,8-甲基二氧基能显著提高生物活性。现有结果表明,QBAs是有前景的候选化合物或开发新型异喹啉杀螨剂的先导化合物。
    DOI:
    10.1248/cpb.c12-00618
点击查看最新优质反应信息

文献信息

  • In Vitro Antifungal Activity of Sanguinarine and Chelerythrine Derivatives against Phytopathogenic Fungi
    作者:Xin-Juan Yang、Fang Miao、Yao Yao、Fang-Jun Cao、Rui Yang、Yan-Ni Ma、Bao-Fu Qin、Le Zhou
    DOI:10.3390/molecules171113026
    日期:——
    In order to understand the antifungal activity of some derivatives of sanguinarine (S) and chelerythrine (C) and their structure-activity relationships, sixteen derivatives of S and C were prepared and evaluated for in vitro antifungal activity against seven phytopathogenic fungi by the mycelial growth rate method. The results showed that S, C and their 6-alkoxy dihydro derivatives S1–S4, C1–C4 and 6-cyanodihydro derivatives S5, C5 showed significant antifungal activity at 100 µg/mL against all the tested fungi. For most tested fungi, the median effective concentrations of S, S1, C and C1 were in a range of 14–50 µg/mL. The structure-activity relationship showed that the C=N+ moiety was the determinant for the antifungal activity of S and C. S1–S5 and C1–C5 could be considered as the precursors of S and C, respectively. Thus, the present results strongly suggested that S and C or their derivatives S1–S5 and C1–C5 should be considered as good lead compounds or model molecules to develop new anti-phytopathogenic fungal agents.
    为了理解血根碱(S)和白屈菜红碱(C)及其衍生物的抗真菌活性和结构-活性关系,制备并评估了十六种S和C衍生物对七种植物病原真菌的体外抗真菌活性,采用菌丝生长速率法进行测定。结果显示,S、C及其6-烷氧基二氢衍生物S1-S4、C1-C4和6-氰基二氢衍生物S5、C5在100 µg/mL浓度下对所有测试真菌均表现出显著的抗真菌活性。对于大多数测试真菌,S、S1、C和C1的中效浓度范围为14-50 µg/mL。结构-活性关系表明,C=N+部分是S和C抗真菌活性的决定因素。S1-S5和C1-C5可以分别被视为S和C的前体。因此,当前结果强烈表明,S和C或其衍生物S1-S5和C1-C5应被视为开发新型抗植物病原真菌剂的优良先导化合物或模型分子。
  • Structural Modification of Sanguinarine and Chelerythrine and Their &lt;i&gt;in Vitro&lt;/i&gt; Acaricidal Activity against &lt;i&gt;Psoroptes cuniculi&lt;/i&gt;
    作者:Fang Miao、Xin-Juan Yang、Yan-Ni Ma、Feng Zheng、Xiao-Ping Song、Le Zhou
    DOI:10.1248/cpb.c12-00618
    日期:——
    Sanguinarine (1) and chelerythrine (2) are two quaternary benzo[c]phenanthridine alkaloids (QBAs). Eighteen derivatives of 1 and 2 were synthesized by modification of C=N+ bond and evaluated for their in vitro acaricidal activity against Psoroptes cuniculi, a mange mite. A new method was developed to prepare 6-alkoxy dihydro derivatives of 1 and 2 (1a–e, 2a–e). Among all the compounds, only 6-alkoxy dihydrosanguinarines (1a–e) showed significant acaricidal activity at 5.0 mg/mL and 1a possessed the strongest activity (50% lethal concentrations (LC50)=339.70±0.75 mg/L, 50% lethal time (LT50)=6.53±0.04 h), comparable with a standard drug ivermectin (LC50=168.19±11.79 mg/L, LT50=16.54±0.11 h). The iminium moiety in 1 and 2 was proven to be the determinant for their acaricidal properties. 6-Alkoxy dihydro derivatives (1a–e, 2a–e) were prodrugs of 1 and 2. Compared with 7,8-dimethoxy groups, 7,8-methylenedioxy group was able to significantly improve the bioactivity. The present results suggested that QBAs are promising candidates or lead compounds for the development of new isoquinoline acaricidal agents.
    血根碱(1)和白屈菜红碱(2)是两种季铵基苯并[c]菲啶生物碱(QBAs)。通过C=N+键的修饰合成了1和2的18个衍生物,并评估了它们对兔耳螨(Psoroptes cuniculi)的体外杀螨活性。开发了一种新方法制备1和2的6-烷氧基二氢衍生物(1a–e,2a–e)。在所有化合物中,只有6-烷氧基二氢血根碱(1a–e)在5.0 mg/mL浓度下显示出显著的杀螨活性,其中1a具有最强的活性(50%致死浓度(LC50)=339.70±0.75 mg/L,50%致死时间(LT50)=6.53±0.04 h),与标准药物伊维菌素(LC50=168.19±11.79 mg/L,LT50=16.54±0.11 h)相当。1和2中的亚胺基团被证实是其杀螨活性的决定因素。6-烷氧基二氢衍生物(1a–e,2a–e)是1和2的前药。与7,8-二甲氧基相比,7,8-甲基二氧基能显著提高生物活性。现有结果表明,QBAs是有前景的候选化合物或开发新型异喹啉杀螨剂的先导化合物。
查看更多

同类化合物

血根黄碱 血根碱 血根碱 血根樹鹼硝酸鹽 紫堇灵 紫堇洛星碱 白屈菜默碱 白屈菜赤碱 白屈菜红碱氯化物 白屈菜红碱 白屈菜红碱 白屈菜碱 白屈菜宾 氯化血根碱水合物 博落回醇碱 博落回提取物 二氢白屈菜红碱 乙酰紫堇灵 乙氧基血根碱 丙酮基白屈菜赤碱 β-高白屈菜碱 N-[7-(6-羟基-1,3-苯并二氧戊环-5-基)苯并[f][1,3]苯并二氧戊环-8-基]-N-甲基甲酰胺 N-[6-(2-羟基-3,4-二甲氧基苯基)萘并[2,3-d][1,3]二氧杂环戊烯-5-基]-N-甲基甲酰胺 6-丙酮基二氢血根碱 4,9,10-三甲氧基-5b,12-二甲基-5b,6,7,11b,12,13-六氢苯并[c][1,3]二噁唑并[4,5-i]5-氮杂菲-6-醇 13,14-二氢血根碱 (5bR,6S,12bS,5b'R,6'S,12b'S,5b''R,6''S,12b''S)-13,13',13''-[硫代磷酰三(亚氨基乙烷-2,1-二基)]三(6-羟基-13-甲基-5b,6,7,12b,13,14-六氢[1,3]苯并二噁唑并[5,6-c][1,3]二噁唑并[4,5-i]5-氮杂菲-13-正离子)三氢氧化 (-)-白屈菜碱 (+)-白屈菜碱盐酸盐 6-(dibutylphosphonyl)-5,6-dihydrochelerythrine chelidonyl-ethyl-oxalic acid diester chelidonyl-phenylalanyl ester N-(3-trifluoromethylphenyl)-chelidonyl-urethane 6-(1′-nitropropyl)-5,6-dihydrochelerythrine 7-hydroxynitidine 6-(diethylmalonyl)-5,6-dihydrochelerythrine 6-(1'-nitroethyl)-5,6-dihydrochelerythrine 2,8-dimethoxy-3,7-dihydroxy-5-methyl-benzo[c]phenanthridinium chloride bis<6-(5,6-dihydrosanguinarinyl)> ether (+)-chelidonine (±)-maclekarpine B bis(dihydrochelirubunyl) ether 13-ethoxy-2,3-dimethoxy-12-methyl-1-phenylmethoxy-13H-[1,3]benzodioxolo[5,6-c]phenanthridine 7-hydroxynitidine hydrogen sulfate (1S,12S,13R,24R)-24-[2-[bis[2-[(1S,12S,13R,24R)-12-hydroxy-24-methyl-5,7,18,20-tetraoxa-24-azoniahexacyclo[11.11.0.02,10.04,8.014,22.017,21]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-24-yl]ethylamino]phosphinothioylamino]ethyl]-24-methyl-5,7,18,20-tetraoxa-24-azoniahexacyclo[11.11.0.02,10.04,8.014,22.017,21]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-12-ol;trihydroxide Ukrain cation 4-Pyridinecarbonitrile, 2-(1-(12,13-dihydro-1,2-dimethoxy-12-methyl(1,3)benzodioxolo(5,6-c)phenanthridin-13-yl)ethyl)-, (R*,S*)- (1,3)Benzodioxolo(5,6-c)phenanthridine-13-methanol, 12,13-dihydro-1-hydroxy-2-methoxy-12-methyl- 2-methoxy-12-methyl-12H-[1,3]benzodioxolo[5,6-c]phenanthridin-12-ium-1-one Nitrotyrasanguinarine